A share price of Moleculin Biotech Inc [MBRX] is currently trading at $0.52, up 1.57%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MBRX shares have gain 3.22% over the last week, with a monthly amount glided 35.35%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Maxim Group downgraded its rating to Hold on February 12, 2025.
Moleculin Biotech Inc experienced fluctuations in its stock price throughout the past year between $0.25 and $3.65. Moleculin Biotech Inc [NASDAQ: MBRX] shares were valued at $0.52 at the most recent close of the market.
Analyzing the MBRX fundamentals
Gross Profit Margin for this corporation currently stands at -0.22% with Operating Profit Margin at -201.91%, Pretax Profit Margin comes in at -210.71%, and Net Profit Margin reading is -210.71%. To continue investigating profitability, this company’s Return on Assets is posted at -1.23, Equity is -16.76 and Total Capital is -1.86. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5042 points at the first support level, and at 0.4923 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5239, and for the 2nd resistance point, it is at 0.5317.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Moleculin Biotech Inc [NASDAQ:MBRX] is 1.15. Further, the Quick Ratio stands at 1.15, while the Cash Ratio is 0.96.
Transactions by insiders
Recent insider trading involved Foster Jonathan P., Chief Financial Officer, that happened on Jun 23 ’25 when 0.27 million shares were purchased. CEO and President, KLEMP WALTER V completed a deal on Jun 23 ’25 to buy 0.68 million shares.
